These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer. Yoshida Y; Tomizawa M; Bahar R; Miyauchi M; Yamaguchi T; Saisho H; Kadomatsu K; Muramatsu T; Matsubara S; Sakiyama S; Tagawa M Anticancer Res; 2002; 22(1A):117-20. PubMed ID: 12017272 [TBL] [Abstract][Full Text] [Related]
5. Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells. Miyauchi M; Yoshida Y; Tada Y; Narita M; Maeda T; Bahar R; Kadomatsu K; Muramatsu T; Matsubara S; Nakagawara A; Sakiyama S; Tagawa M Int J Cancer; 2001 Mar; 91(5):723-7. PubMed ID: 11267987 [TBL] [Abstract][Full Text] [Related]
6. Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells. Yu L; Hamada K; Namba M; Kadomatsu K; Muramatsu T; Matsubara S; Tagawa M Eur J Cancer; 2004 Jul; 40(11):1787-94. PubMed ID: 15251170 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter. Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481 [TBL] [Abstract][Full Text] [Related]
8. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21. Hanari N; Matsubara H; Hoshino I; Akutsu Y; Nishimori T; Murakami K; Sakata H; Miyazawa Y; Ochiai T Anticancer Res; 2007; 27(4B):2305-10. PubMed ID: 17695518 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. Wang Q; Beck WT Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734 [TBL] [Abstract][Full Text] [Related]
10. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter. Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430 [TBL] [Abstract][Full Text] [Related]
11. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells. Li C; Ahlborn TE; Tokita K; Boxer LM; Noda A; Liu J Oncogene; 2001 Dec; 20(57):8193-202. PubMed ID: 11781835 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug. Kawamura K; Yu L; Tomizawa M; Shimozato O; Ma G; Li Q; Sato A; Yang Y; Suzuki T; Abdel-Aziz NM; Tagawa M Anticancer Res; 2007; 27(1A):89-93. PubMed ID: 17352220 [TBL] [Abstract][Full Text] [Related]
13. Midkine promoter can mediate transcriptional activation of a fused suicide gene in a broader range of human breast cancer compared with c-erbB-2 promoter. Yu L; Yamamoto N; Kadomatsu K; Muramatsu T; Matsubara S; Sakiyama S; Tagawa M Oncology; 2004; 66(2):143-9. PubMed ID: 15138367 [TBL] [Abstract][Full Text] [Related]
14. Tissue-specific expression of a suicide gene for selective killing of neuroblastoma cells using a promoter region of the NCX gene. Narita M; Bahar R; Hatano M; Kang MM; Tokuhisa T; Goto S; Saisho H; Sakiyama S; Tagawa M Cancer Gene Ther; 2001 Dec; 8(12):997-1002. PubMed ID: 11781663 [TBL] [Abstract][Full Text] [Related]
15. p53 upregulates death receptor 4 expression through an intronic p53 binding site. Liu X; Yue P; Khuri FR; Sun SY Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308 [TBL] [Abstract][Full Text] [Related]
16. Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications. Casado E; Gomez-Navarro J; Yamamoto M; Adachi Y; Coolidge CJ; Arafat WO; Barker SD; Wang MH; Mahasreshti PJ; Hemminki A; Gonzalez-Baron M; Barnes MN; Pustilnik TB; Siegal GP; Alvarez RD; Curiel DT Clin Cancer Res; 2001 Aug; 7(8):2496-504. PubMed ID: 11489832 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D; Masri S; Ye JJ; Chen S Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749 [TBL] [Abstract][Full Text] [Related]
18. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer. Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423 [TBL] [Abstract][Full Text] [Related]
19. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer. Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225 [TBL] [Abstract][Full Text] [Related]
20. Identification of a minimal c-erbB-2 promoter region that mediates preferential expression of a linked foreign gene in human breast cancer cells. Yu L; Kamo S; Tagawa M Int J Oncol; 2002 Mar; 20(3):607-10. PubMed ID: 11836576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]